Basic Information
RNALocate ID: | RLID:01001209 |
RNA Symbol: | hsa-let-7c-5p |
Localization: | Cytoplasm |
RNA Information
RNA Name: | hsa-let-7c |
RNA ID: | miRBase:MIMAT0000064 |
RNA Category: | miRNA |
Species: | Homo sapiens |
Localization Information
PubMed ID: | 21695135 |
Tissue/Cell Line: | Cell line (HeLa) |
Method: | Microarray |
Heatmap showing the 57 miRNAs differentially expressed in HeLa cells from mitochondrial and cytosolic RNA. Three independent microarray profiling experiments (microarray n1, n2 and n3) are shown and reproducibly revealed 13 miRNAs enriched in mitochondrial RNA. Originally published in PLoS One. Bandiera S, et al, 2011. Reproduced under the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/) |
|
Description: | While 44 miRNAs showed a greater enrichment in the cytosolic Hy3-labeled RNA fraction, 13 miRNAs were significantly and reproducibly enriched in the mitochondrial Hy5-labeled RNA sample (ranging from 1.5- to 56-fold), namely hsa-miR-1973, hsa-miR-1275, hsa-miR-494, hsa-miR-513a-5p, hsa-miR-1246, hsa-miR-328, hsa-miR-1908, hsa-miR-1972, hsa-miR-1974, hsa-miR-1977, hsa-miR-638, hsa-miR-1978 and hsa-miR-1201 (Figure 5A). Data are collected from Figure 5. |
Other Subcellular Localization
RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
RLID:01001208 | Cytoplasm | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001210 | Cytoplasm | HeLa cells | 22058130 |
RLID:01001211 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001212 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
RLID:01001213 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
RLID:01001214 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001215 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
RLID:01001216 | Nucleus | Nasopharyngeal carcinoma cells | 20498841 |
RLID:01001217 | Nucleus | Colon adenocarcinoma cells | 20864815 |
RLID:01001218 | Nucleus | HeLa cells | 22058130 |
RLID:11000594 | Exosome | Saliva | 19627513 |
RLID:11000595 | Exosome | Hetastatic gastric cancer cell line (AZ-P7a) | 20949044 |
RLID:11000596 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
RLID:11000597 | Exosome | Primary dendritic cells | 21505438 |
RLID:11000598 | Exosome | Renal cancer cells | 21670082 |
RLID:11000599 | Exosome | Breast milk | 22211110 |
RLID:11000600 | Exosome | Malignant melanoma cell line (A375) | 23056502 |
RLID:11000601 | Exosome | Saliva | 23302638 |
RLID:11000602 | Exosome | Brain tissue | 23382797 |
RLID:11000603 | Exosome | Plasma | 23663360 |
RLID:11000604 | Exosome | Human mast cell line (HMC-1) | 24009880 |
RLID:11000605 | Exosome | Human esophageal cancer cell line (EC9706) | 25184951 |
RLID:11000606 | Extracellular vesicle | HEK-293T cells | 22849433 |
RLID:11000607 | Microvesicle | Plasma | 23077538 |
RLID:11000608 | Microvesicle | Seminal plasma | 23539611 |
RLID:11000609 | Microvesicle | Follicular fluid | 23666971 |
RLID:11000610 | Microvesicle | Hepatoma cells | 23771658 |
RLID-D:11000003 | Exosome | Blood|Breast milk|Chronic lymphocytic leukemia cells|Endothelial cells|Lymphoma tissue|Saliva|Seminal fluid | |
RLID-D:11000263 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
Resource | RNA Symbol | Disease | Link |
MNDR | hsa-let-7c-5p | Diffuse large b cell lymphoma | MNDR-E-MI-00967 |
MNDR | hsa-let-7c-5p | Splenic marginal zone lymphoma | MNDR-E-MI-00968 |
MNDR | hsa-let-7c-5p | Oral squamous cell carcinoma | MNDR-E-MI-00969 |
MNDR | hsa-let-7c-5p | Large cell neuroendocrine cancer | MNDR-E-MI-00970 |
MNDR | hsa-let-7c-5p | B cell lymphoma of malt type | MNDR-E-MI-00971 |
MNDR | hsa-let-7c-5p | High-grade serous ovarian carcinoma | MNDR-E-MI-00972 |
MNDR | hsa-let-7c-5p | Ovarian clear cell carcinoma | MNDR-E-MI-00973 |
MNDR | hsa-let-7c-5p | Uterine corpus endometrial carcinoma | MNDR-E-MI-00974 |
MNDR | hsa-let-7c-5p | Lymphoma non-hodgkin | MNDR-E-MI-00975 |
MNDR | hsa-let-7c-5p | Estrogen-receptor positive breast cancer | MNDR-E-MI-00976 |
MNDR | hsa-let-7c-5p | Estrogen-receptor negative breast cancer | MNDR-E-MI-00977 |
MNDR | hsa-let-7c-5p | Progesterone-receptor positive breast cancer | MNDR-E-MI-00978 |
MNDR | hsa-let-7c-5p | Progesterone-receptor negative breast cancer | MNDR-E-MI-00979 |
MNDR | hsa-let-7c-5p | Her2-receptor positive breast cancer | MNDR-E-MI-00980 |
MNDR | hsa-let-7c-5p | Prostate cancer | MNDR-E-MI-00981 |
MNDR | hsa-let-7c-5p | Gastric cancer | MNDR-E-MI-00982 |
MNDR | hsa-let-7c-5p | Gastric lymphoma | MNDR-E-MI-00983 |
MNDR | hsa-let-7c-5p | Alzheimer disease | MNDR-E-MI-00984 |
MNDR | hsa-let-7c-5p | Bladder cancer | MNDR-E-MI-00985 |
MNDR | hsa-let-7c-5p | Dysautonomia familial | MNDR-E-MI-00986 |
MNDR | hsa-let-7c-5p | Head and neck cancer | MNDR-E-MI-00987 |
MNDR | hsa-let-7c-5p | Leukemia | MNDR-E-MI-00988 |
MNDR | hsa-let-7c-5p | Cardiovascular disease | MNDR-E-MI-00989 |
MNDR | hsa-let-7c-5p | Carotid stenosis | MNDR-E-MI-00990 |
MNDR | hsa-let-7c-5p | Lung cancer | MNDR-E-MI-00991 |
MNDR | hsa-let-7c-5p | Metabolic syndrome x | MNDR-E-MI-00992 |
MNDR | hsa-let-7c-5p | Parkinson disease | MNDR-E-MI-00993 |
MNDR | hsa-let-7c-5p | Breast cancer | MNDR-E-MI-00994 |
MNDR | hsa-let-7c-5p | Neuroendocrine neoplasia | MNDR-E-MI-00995 |
MNDR | hsa-let-7c-5p | Pancreatic cancer | MNDR-E-MI-00996 |
MNDR | hsa-let-7c-5p | Melanoma | MNDR-E-MI-00997 |
MNDR | hsa-let-7c-5p | Rectum adenocarcinoma | MNDR-E-MI-00998 |
MNDR | hsa-let-7c-5p | Nephroblastoma | MNDR-E-MI-00999 |
MNDR | hsa-let-7c-5p | Colon cancer | MNDR-E-MI-01000 |
MNDR | hsa-let-7c-5p | Colon adenocarcinoma | MNDR-E-MI-01001 |
MNDR | hsa-let-7c-5p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-01002 |
MNDR | hsa-let-7c-5p | Familial ovarian cancer | MNDR-E-MI-01003 |
MNDR | hsa-let-7c-5p | Prostate adenocarcinoma | MNDR-E-MI-01004 |
MNDR | hsa-let-7c-5p | Carcinoma ductal breast | MNDR-E-MI-01005 |
MNDR | hsa-let-7c-5p | Glioma | MNDR-E-MI-01006 |
MNDR | hsa-let-7c-5p | Chordoma | MNDR-E-MI-01007 |
MNDR | hsa-let-7c-5p | Amyotrophic lateral sclerosis | MNDR-E-MI-01008 |
MNDR | hsa-let-7c-5p | Osteosarcoma | MNDR-E-MI-01009 |
MNDR | hsa-let-7c-5p | Middle cerebral artery infarction | MNDR-E-MI-01010 |
MNDR | hsa-let-7c-5p | Hepatocellular cancer | MNDR-E-MI-01011 |
MNDR | hsa-let-7c-5p | Uterine cancer | MNDR-E-MI-01012 |
MNDR | hsa-let-7c-5p | Cervical adenocarcinoma | MNDR-E-MI-01013 |
MNDR | hsa-let-7c-5p | Gastric adenocarcinoma | MNDR-E-MI-01014 |
MNDR | hsa-let-7c-5p | Cervical squamous cell carcinoma | MNDR-E-MI-01015 |
MNDR | hsa-let-7c-5p | Lung squamous cell carcinoma | MNDR-E-MI-01016 |
MNDR | hsa-let-7c-5p | Lung adenocarcinoma | MNDR-E-MI-01017 |
MNDR | hsa-let-7c-5p | Thyroid carcinoma | MNDR-E-MI-01018 |
MNDR | hsa-let-7c-5p | Tuberculosis | MNDR-E-MI-01019 |
MNDR | hsa-let-7c-5p | Ovarian carcinoma | MNDR-E-MI-01020 |
MNDR | hsa-let-7c-5p | Bladder urothelial carcinoma | MNDR-E-MI-01021 |
MNDR | hsa-let-7c-5p | Pancreatic adenocarcinoma | MNDR-E-MI-01022 |
MNDR | hsa-let-7c-5p | Myasthenia gravis | MNDR-E-MI-01023 |
MNDR | hsa-let-7c-5p | Carcinoma renal cell | MNDR-E-MI-01024 |
MNDR | hsa-let-7c-5p | Kidney renal papillary cell carcinoma | MNDR-E-MI-01025 |
MNDR | hsa-let-7c-5p | Clear cell renal cell carcinoma | MNDR-E-MI-01026 |
MNDR | hsa-let-7c-5p | Large cell carcinoma | MNDR-E-MI-01027 |
MNDR | hsa-let-7c-5p | Biliary tract cancer | MNDR-E-MI-01028 |
MNDR | hsa-let-7c-5p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-01029 |
MNDR | hsa-let-7c-5p | Cholangiocarcinoma | MNDR-E-MI-01030 |
MNDR | hsa-let-7c-5p | Esophageal cancer | MNDR-E-MI-01031 |
MNDR | hsa-let-7c-5p | Head and neck squamous cell carcinoma | MNDR-E-MI-01032 |
MNDR | hsa-let-7c-5p | Adenoma | MNDR-E-MI-01033 |
MNDR | hsa-let-7c-5p | Breast invasive carcinoma | MNDR-E-MI-01034 |
MNDR | hsa-let-7c-5p | Early hepatocellular carcinoma | MNDR-E-MI-01035 |
MNDR | hsa-let-7c-5p | Familiar ovarian carcinoma | MNDR-E-MI-01036 |
MNDR | hsa-let-7c-5p | B-cell lymphoma | MNDR-E-MI-01037 |
MNDR | hsa-let-7c-5p | Rheumatoid arthritis | MNDR-E-MI-01038 |
MNDR | hsa-let-7c-5p | T-cell leukemia | MNDR-E-MI-01039 |
MNDR | hsa-let-7c-5p | Retinoblastoma | MNDR-E-MI-01040 |
MNDR | hsa-let-7c-5p | Neuroblastoma | MNDR-E-MI-01041 |
MNDR | hsa-let-7c-5p | Barrett's adenocarcinoma | MNDR-E-MI-01042 |
MNDR | hsa-let-7c-5p | Hodgkin lymphoma | MNDR-E-MI-01043 |
MNDR | hsa-let-7c-5p | Burkitt lymphoma | MNDR-E-MI-01044 |
MNDR | hsa-let-7c-5p | Tonsil cancer | MNDR-E-MI-01045 |
MNDR | hsa-let-7c-5p | Neuromyelitis optica | MNDR-E-MI-01046 |
MNDR | hsa-let-7c-5p | Acute myeloid leukemia | MNDR-E-MI-01047 |
MNDR | hsa-let-7c-5p | Colorectal cancer | MNDR-E-MI-01048 |
MNDR | hsa-let-7c-5p | Nasopharynx carcinoma | MNDR-E-MI-01049 |
MNDR | hsa-let-7c-5p | Multiple myeloma | MNDR-E-MI-01050 |
MNDR | hsa-let-7c-5p | Prostatic neoplasms | MNDR-E-MI-01051 |
MNDR | hsa-let-7c-5p | Reperfusion injury | MNDR-E-MI-01052 |
MNDR | hsa-let-7c-5p | Epstein-barr virus infections | MNDR-E-MI-01053 |
MNDR | hsa-let-7c-5p | Barrett's carcinogenesis | MNDR-E-MI-01054 |
MNDR | hsa-let-7c-5p | Breast cancer her3+ negative | MNDR-E-MI-01055 |
MNDR | hsa-let-7c-5p | High grade dysplastic nodule | MNDR-E-MI-01056 |
MNDR | hsa-let-7c-5p | Tubulovillous adenoma | MNDR-E-MI-01057 |
RNA Interaction Information
Resource | RNA Symbol | Species | Link | RNALocate ID |
RNAInter | ABCC5 | Homo sapiens | RR00023746 |
TOP